rts logo

A peek at Pulmonx Corp (LUNG): Who has invested in It?

Pulmonx Corp (NASDAQ: LUNG) is -50.59% lower on its value in year-to-date trading and has touched a low of $5.46 and a high of $14.84 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LUNG stock was last observed hovering at around $6.46 in the last trading session, with the day’s loss setting it -0.16%.

Currently trading at $6.30, the stock is -6.15% and -9.49% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.17 million and changing -2.48% at the moment leaves the stock -18.39% off its SMA200. LUNG registered -42.93% loss for a year compared to 6-month loss of -13.70%. The firm has a 50-day simple moving average (SMA 50) of $7.0024 and a 200-day simple moving average (SMA200) of $7.7594.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -6.94% gain in the last 1 month and extending the period to 3 months gives it a -13.93%, and is 1.61% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.06% over the week and 7.43% over the month.

Pulmonx Corp (LUNG) has around 279 employees, a market worth around $248.77M and $79.30M in sales. Profit margin for the company is -72.01%. Distance from 52-week low is 15.38% and -57.53% from its 52-week high. The company has generated returns on investments over the last 12 months (-38.33%).

The EPS is expected to grow by 2.61% this year

164.0 institutions hold shares in Pulmonx Corp (LUNG), with institutional investors hold 100.06% of the company’s shares. The shares outstanding are 38.52M, and float is at 35.76M with Short Float at 2.36%. Institutions hold 94.90% of the Float.

The top institutional shareholder in the company is PRIMECAP MANAGEMENT CO/CA/ with over 5.71 million shares valued at $36.2 million. The investor’s holdings represent 14.7787 of the LUNG Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 5.28 million shares valued at $33.48 million to account for 13.6686 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 3.47 million shares representing 8.984 and valued at over $22.01 million, while BLACKROCK INC. holds 6.9049 of the shares totaling 2.67 million with a market value of $16.91 million.

Pulmonx Corp (LUNG) Insider Activity

The most recent transaction is an insider sale by French Glendon E. III, the company’s Director. SEC filings show that French Glendon E. III sold 20,000 shares of the company’s common stock on Nov 22 ’24 at a price of $6.63 per share for a total of $0.13 million. Following the sale, the insider now owns 1.07 million shares.

Still, SEC filings show that on Oct 17 ’24, French Glendon E. III (Director) disposed off 20,000 shares at an average price of $6.52 for $0.13 million. The insider now directly holds 1,091,974 shares of Pulmonx Corp (LUNG).

Related Posts